MDCK-MDR1 assay
The permeability of the test compounds was assessed in MDCK-MDRI cells that were cultured to confluency (4-6 days) in a 96 transwell plate. Test compounds were diluted with the transport buffer (HBSS + 1% BSA) to a concentration of 0.5 µM and applied to the apical or basolateral side of the cell monolayer. Permeation of the test compounds from A to B direction or B to A direction was determined in triplicate over a 60-minute incubation time at 37 °C and 5% CO 2 with a relative humidity of 95%. Test compounds were quantified by LC-MS/MS analysis based on the peaks area ratios of analyte/lS in both the receiver and donor wells of the transwell plate. The apparent permeability coefficient Papp (cm/s) was calculated using the equation: Papp = (dCr/dt) x Vr / (A x C0) Where dCr/dt is the cumulative concentration of compound in the receiver chamber as a function of time (gM/s); Vr is the solution volume in the receiver chamber (0.05 mL on the apical side; 0.25 mL on the basolateral side); A is the surface area for the transport, i.e. 0.0804 cm 2 for the area of the monolayer; C0 is the initial concentration in the donor chamber (µM). The final MDCK-MDR1 efflux ratio is then calculated Papp BA / Papp AB.
Determination of pK a values
The pKa values are determined by a series of three titrations on a dilution of 10µL 10µM compound stock at 25.0 + 0.5 °C and ion strength of 0.16M using methanol as co-solvent. Methanol concentrations in the range 29 -54% were used in the three titrations on each compound. The titrator is used in the mode with a diode-array-detector. This detector recorded the UV-Vis spectrum of the solution in-line, and thus the titration can be mapped via comparison to the spectra of the protonated and unprotonated species. The real aqueous pK a -value was determined by extrapolation to zero-methanol content using a Yasuda-Shedlovsky plot.
PDE9 inhibition assay
The assay is performed in 60 µL samples containing a fixed amount of the PDE9 enzyme (sufficient to convert not more than 20% of the tritiated substrate), a buffer (50 mM HEPES pH 7.6; 10 mM MgCl 2 ; 0.02% Tween20), 0.1mg/ml BSA, and tritium labeled cGMP to a final concentration of 15 nM and varying amounts of inhibitors. Reactions are initiated by addition of 3 H-cGMP, and reactions are allowed to proceed for 1 hour at room temperature before being terminated through mixing with 15 µL 8 mg/mL yttrium silicate SPA beads (Amersham). The beads are allowed to settle for 1 hour in the dark before the plates are counted in a Wallac 1450 Microbeta counter. The measured signal is converted to activity relative to an uninhibited control (100 %) and IC 50 values are calculated using the Xlfit (IDBS) extension to EXCEL.
Syntheses General procedure for the reductive amination
To a stirred solution of 1, 2, 6 or 7 (1 equiv.) in MeOH (0.05M wrt. 1, 2, 6 or 7) was slowly added HCl (70 equiv., 4M in dioxane) at rt. The mixture was subsequently stirred 1.5 h followed by a removal of solvent at reduced pressure. To this material was then added 1,2-DCE (0.02M wrt. 1, 2, 6 or 7) and sodium acetate (3 equiv.) followed by the aldehyde (1.5 equiv.) and sodium triacetoxyborohydride (2.5 equiv.) after which the mixture was heated at 40 °C for 1.5 h. Saturated aq. NaHCO 3 was added and the aqueous phase extracted with CH 2 Cl 2 after which the combined organic phases were dried over MgSO 4 , filtered and concentrated in vacuo to provide a crude material that was purified using silica gel chromatography (85:10:5, EtOAc:MeOH:Et 3 N) to provide 8-11.
tert-Butyl
(3R,4R)-3-fluoro-4-methyl-3-(4-oxo-1-(tetrahydro-2H-pyran-4-yl)-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)pyrrolidine-1-carboxylate (1): To a mixture of 4 (1.00 g, 4.32 mmol) and 3 (1.09 g, 5.19 mmol) in THF (8.6 mL, 0.5M) was added Ti(OEt) 4 (7.89 g, 7.25 mL, 34.6 mmol) and the mixture was stirred for 24 h at 75 °C. Water was added followed by EtOAc and the dense mixture was passed through a plug of Celite. The mixture was extracted with ethyl acetate. The organic phase was washed with brine, dried over MgSO 4 and concentrated in vacuo to provide the crude aminal intermediate that was dried overnight at reduced pressure. To the dried residue was added CH 2 Cl 2 (4 mL) and DMF 
S4
(29 mL, 4.32 mmol, 0.15M) and the resulting mixture was heated to 80 °C followed by the addition of I 2 (1.646 g, 6.49 mmol). After 30 min at 80 °C, the heating block was removed and the mixture allowed to cool for 5 min, followed by the addition of sat. aq. NaHCO 3 (15 mL) and 10% aq. Na 2 S 2 O 3 (35 mL). EtOAc was added and the phases separated, the aqueous phase was extracted with EtOAc (2 x 200 mL) and once with EtOAc/THF (150 mL, 1:1). The combined organic extracts were washed with brine, dried over MgSO 4 , filtered and concentrated in vacuo to provide a brown residue that was purified using silica gel chromatography to provide 1 (661 mg, 1.568 mmol, 36% yield) as a yellow oil.
Note: if heating is continued at 80 °C past 30 min in step 2, significant amounts of product will get Boc de-protected. It is then possible to add sat. aq. bicarb, 10% aq. sodium thiosulphate, EtOAc and re-install the Boc in situ using cat. 4-DMAP and Boc-anhydride and recover the material by extraction.
13 C NMR (151 MHz, CDCl 3 ) δ 157. 4, 154.9, 154.8, 154.7, 154.6, 154.2, 153.8, 151.1, 151.0, 135.1, 105.3, 101.8 
tert-Butyl (3S,4S)-3-methyl-4-(4-oxo-1-(tetrahydro-2H-pyran-4-yl)-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)pyrrolidine-1-carboxylate (2):
To a mixture of 5 (1.00 g, 4.32 mmol) and 3 (1.18 g, 5.63 mmol) in THF (9.4 mL, 0.5M) was added Ti(OEt) 4 (8.56 g, 7.86 mL, 37.5 mmol) and the mixture was stirred for 24 h at 75 °C. The reaction mixture was then poured into water (100 mL) and the resulting suspension was heavily stirred for 10 min after which EtOAc was added and the dense mixture was passed through a plug of Celite. The mixture was extracted with ethyl acetate. The organic phase was washed with brine, dried over MgSO 4 and concentrated in vacuo to provide a yellow residue that was taken up in CH 2 Cl 2 (15 mL) and transferred to a round-bottom flask. The suspension was boiled and DMF (31 mL, 0.15M) was added while allowing the temperature to reach 80 °C followed by the addition of I 2 (1.785 g, 7.03 mmol). The reaction mixture was stirred for 20 min followed by the addition of sat. aq. NaHCO 3 (30 mL) and 10% sat. aq. Na 2 S 2 O 3 . EtOAc was added and the phases were separated. The aqueous phase was extracted using EtOAc (2 x 150 mL) followed by EtOAc:THF (200 mL, 1:1). The combined organic layers were washed with brine, dried over MgSO 4 , filtered and concentrated in vacuo to provide a crude residue that was further purified using silica gel chromatography to provide 2 (1.05 g, 2.60 mmol, 56% yield) as a yellow oil. The characterization data are in accordance with literature. in DMF (540 µL 0.65M) was added NaH (15.5 mg, 0.386 mmol, 60%) and the resulting mixture was stirred for 30 min at 0 °C. MeI (75 mg, 33 µL, 0.53 mmol) was added and stirring was continued for 1.5 h. Water and NH 4 Cl were added. The mixture was extracted with EtOAc. The organic phase was washed with brine, dried over MgSO 4 and concentrated in vacuo. The crude material was purified using silica gel chromatography to provide 6 (20.0 mg, 0.046 mmol, 13% yield) as a colorless oil. 
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6-((3S,4S)-1-Isobutyl-4-methylpyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (9c):
Synthesized using the general procedure to provide 9c in 33% yield. 
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6-((3R,4R)-3-Fluoro-1-isobutyl-4-methylpyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (8c):
Synthesized using the general procedure to provide 8c in 33% yield. 1, 161.4, 157.3, 157.1, 135.1, 134.2, 130.3, 130.3, 115.5, 115.4, 105.1, 102.5 (d, J = 189.2 Hz), 67.1, 64.7 (d, J = 23.8 Hz), 59.7, 54.3, 43.6 (d, J = 20.6 3R,4R)-3-fluoro-4-methyl-1-((5-methylpyrazin-2-yl)methyl)pyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d] pyrimidin-4-one (8e): Synthesized using the general procedure to provide 8e in 35% yield. 6, 158.8, 152.5, 150.9, 150.0, 143.9, 143.7, 134.8, 104.1, 67.2 (2C), 61.3, 59.3, 59.0, 54.2, 50.8, 37.8, 32.4, 32.3, 30.5, 21.4, 18.9 . 59.6, 55.1, 54.4, 43.9, 43.7, 32.3, 10.11 (d, J = 9.9 Hz 4, 160.6, 158.8, 157.3, 150.0, 134.8, 128.7, 104.2, 67.2 (2C), 61.1, 58.8, 54.8, 54.4, 50.7, 37.8, 32.4, 32.2, 30.5, 25.9, 19 .3. APT spectrum of 1 acquired in CDCl 3 . 
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